Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy

A human memory T cell subset with stem cell–like properties

Luca Gattinoni, Enrico Lugli, Yun Ji et al. · Nature Medicine · 2011 · 1.9K citations · Full text

Life Sciences, Cell Biology, Immunology +12

Infusions of Donor Leukocytes to Treat Epstein-Barr Virus-Associated Lymphoproliferative Disorders after Allogeneic Bone Marrow Transplantation

Esperanza B. Papadopoulos, Marc Ladanyi, David Emanuel et al. · New England Journal of Medicine · 1994 · 1.1K citations · Full text

Medicine, Hematology, Immunology +12

Long–term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene–modified virus–specific T lymphocytes

Helen E. Heslop, Catherine Y. Ng, Congfen Li et al. · Nature Medicine · 1996 · 833 citations

Life Sciences, Immunology, Infectious Diseases +13

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

Helen E. Heslop, Karen S. Slobod, Martin Pulé et al. · Blood · 2009 · 778 citations · Full text

Life Sciences, Hematology, Immunology +17

Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial

Tanzina Haque, Gwen Wilkie, Marie M. Jones et al. · Blood · 2007 · 644 citations

Life Sciences, Hematology, Immunology +15